Pr Jones from School of Pharmacy and Biomolecular Sciences, University of Brighton, United Kingdom will talk about will talk about his study on “Development of Infection-responsive surface coatings for bacteriophage delivery in the catheterised urinary tract“.
He summarizes his talk in following:
“Indwelling urethral catheters (IUC) are widely used for long-term bladder management but are often complicated by acquisition of infection. Proteus mirabilis is a particular problem in this regard, and forms extensive crystalline biofilms on catheter surfaces that obstruct urine flow and lead to serious complications such as pyelonephritis, septicaemia and shock. To address this clinical need, we have developed a novel infection-responsive surface coating for urinary catheters, which responds to elevated pH indicative of P. mirabilis infection. We demonstrate the ability of this coating to provide both a visual early warning of infection, and deliver a therapeutic dose of bacteriophage to control catheter blockage. This potentially “theranostic” coating system is a promising strategy for the deployment of phage therapy and other relevant antimicrobial compounds at local sites within the urinary tract at the exact time when the intervention is needed.”
If you are interested to know more about Phage and phage-based products, don’t hesitate to participate to Targeting Antibiotic Resistance Congress which will be held in Florence on October 2-3, 2017. More information on www.tid-site.com/